ArticleScientific reports2025
A cross-sectional study on schistosomiasis prevalence, intensity and risk factors in Kassala State, Sudan.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite decade-long global efforts, schistosomiasis remains a significant concern in Sudan. In 2017, a nationwide survey on schistosomiasis raised concerns about the existence of persistent "hot spot" areas that require more focused interventions and resources. The Sudanese Federal Ministry of Health (FMOH) and the Kassala State Ministry of Health have continued to implement school-based MDA. This study aimed to assess the prevalence and intensity of Schistosoma mansoni and S. haematobium infections and to identify associated demographic and environmental risk factors in high-endemic communities in Kassala State, Sudan. We conducted a community-based cross-sectional survey between 24th January and 13th February 2023 across 40 purposively selected villages in New Halfa and Nahr Atbara localities. Stool and urine samples were collected from 3,889 residents of all ages. S. mansoni infection was diagnosed via the Kato-Katz technique, and S. haematobium via urine centrifugation. Prevalence and infection intensity were modeled using a double hurdle model. Additional sociodemographic and behavioral data were collected through structured household interviews. The prevalence of Schistosoma mansoni in New Halfa and Nahr Atbara was 28.0% and 24.3%, respectively. In contrast, the prevalence of Schistosoma haematobium was relatively low, with a rate of 2.1% in New Halfa and no infections detected in Nahr Atbara. For S. mansoni, one village exhibited the highest prevalence of 68.2%. Out of 40 villages identified as potential hotspots, 25 had a prevalence exceeding 20%. In contrast, S. haematobium was found in only a few villages in New Halfa, with prevalence surpassing 10% in two of the 40 villages. The prevalence of infection among individuals aged 20 and older remained high in the identified villages. These findings suggest that the current mass drug administration (MDA)-only approach, which focuses primarily on school-aged children, is insufficient to prevent persistent reinfection at the local level. Therefore, updated guidelines tailored to the national context, expanded MDA with microplanning, awareness campaigns across all age groups, and improvements in water and sanitation are crucial components for effective schistosomiasis control. Moreover, the interruption of annual MDA programs due to civil conflict and reduced access to medication has exacerbated the situation, underscoring the urgent need for international attention and support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.